Hongfei Chen (H Chen)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Postoperative Pain

Monoclonal Antibody

Left Ventricular

Pain Management

Top Venues

Human & experimental toxicology

BMC pharmacology & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Hongfei Chen, Z Jin, Zhi Jian Fu, Fangfang Xia
SK2 channel deletion reduces susceptibility to bupivacaine-induced cardiotoxicity in mouse. Human & experimental toxicology 40 (10) (2021)
Hongfei Chen, F Xia, X Chen, Y Cai, Z Jin
Ablation of small conductance calcium-activated potassium type-2 channel (SK2) delays occurrence of bupivacaine-induced cardiotoxicity in isolated mouse hearts. Human & experimental toxicology 40 (3) (2020)
F Xia, Hongfei Chen, Z Jin, Zhi Jian Fu
Apelin-13 protects the lungs from ischemia-reperfusion injury by attenuating inflammatory and oxidative stress. Human & experimental toxicology 40 (4) (2020)
Fangfang Xia, Zhousheng Jin, Tingting Lin, Xixi Cai, Linmin Pan, Shi Wang, Yaoyao Cai, Hongfei Chen
Dexmedetomidine enhances tolerance to bupivacaine cardiotoxicity in the isolated rat hearts: alpha 2 adrenoceptors were not involved. BMC pharmacology & toxicology 20 (1) (2019)